Orphazyme Major Investor Sunstone Cut Stake After Retail Investor-Driven Rally
Orphazyme A/S’s (NASDAQ: ORPH) major shareholder Sunstone Life Science Ventures has reduced its stake following the retail investor-driven rally in the Denmark-based biopharmaceutical company’s shares.